Drug Shortage Report for ETOPOSIDE INJECTION
| Report ID | 61368 |
| Drug Identification Number | 02080036 |
| Brand name | ETOPOSIDE INJECTION |
| Common or Proper name | ETOPOSIDE |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | ETOPOSIDE |
| Strength(s) | 20MG |
| Dosage form(s) | LIQUID |
| Route of administration | INTRAVENOUS |
| Packaging size | 25ML |
| ATC code | L01CB |
| ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2018-09-12 |
| Estimated end date | 2020-03-31 |
| Actual end date | 2020-03-15 |
| Shortage status | Resolved |
| Updated date | 2020-03-16 |
| Company comments | Allocating Inventory until next supply (1/31) for 100% of Market, will then be out until end of March. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2019-06-27 | French | Compare |
| v8 | 2019-06-27 | English | Compare |
| v7 | 2019-04-11 | French | Compare |
| v6 | 2019-04-11 | English | Compare |
| v5 | 2018-12-12 | French | Compare |
| v4 | 2018-12-12 | English | Compare |
| v3 | 2018-09-13 | English | Compare |
| v2 | 2018-09-12 | French | Compare |
| v1 | 2018-09-12 | English | Compare |